Since November 29, 2019, the Government of Russia has changed the rules for introducing drugs into civilian circulation.

Mandatory certification or the adoption of a declaration of conformity of medicine (other than immunobiological drugs) is replaced by the manufacturers or importers submitting the relevant information about the drug to the Federal Service for Supervision of Healthcare (Roszdravnadzor).

The purpose of the changes is to create an effective mechanism for the “output” control of drugs entering the civilian circulation.

Thus, drugs will be allowed for selling on the market after receiving assessments from the testing laboratories of federal institutions. Moreover, to assess the quality of drug samples can be sent to other accredited laboratories.